| Line Item | 2022-10-01 | Y/Y |
|---|---|---|
| Revenue | $14.49B | +4.7% |
| Cost of Revenue | $12.12B | +6.8% |
| R&D Expense | $81.0M | -10.0% |
| SG&A Expense | $850.0M | -2.0% |
| Operating Income | $1.24B | -3.9% |
| Pre-tax Income | $934.0M | +3.2% |
| Income Tax | $168.0M | -2.3% |
| Net Income | $766.0M | +4.5% |
| EPS (Basic) | $5.87 | +7.7% |
| EPS (Diluted) | $5.77 | +8.9% |
| Line Item | 2022-10-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.41B | +29.2% |
| Accounts Receivable | $1.78B | -5.4% |
| Inventory | $1.80B | -5.5% |
| Current Assets | $5.16B | +1.4% |
| Total Assets | $16.96B | -5.2% |
| Current Liabilities | $2.84B | -10.7% |
| Long-term Debt | $9.24B | -2.1% |
| Line Item | 2022-10-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.56B | -1.1% |
| Capital Expenditures | $687.0M | +1.6% |
| Investing Cash Flow | -$483.0M | +5.5% |
| Financing Cash Flow | -$704.0M | +5.0% |
| Free Cash Flow | $876.0M | -3.1% |
| Total Liabilities |
| $13.76B |
| -6.4% |
| Stockholders' Equity | $3.20B | +0.5% |